Publication | Closed Access

Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when psa levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model

UrologyCancer EpidemiologyGenitourinary CancerCancer DetectionCancer ScreeningMedicineFree Prostate-specific AntigenBenign Prostatic HyperplasiaProstatic DiseasePublic HealthOncologyRadiologyHigh Risk